|
2023
|
Invention
|
3 receptor antagonists. 32/332/32/3 receptors. |
|
|
P/S
|
Pharmaceuticals, medical and veterinary preparations; healthcare formulations, adapted for medica... |
|
|
P/S
|
Marketing services intended for pharmaceutical products for
diagnosis, prevention, therapy or pr... |
|
|
P/S
|
Teaching; Training; Arranging and conducting of conventions, events, congresses, seminars, confer... |
|
2022
|
Invention
|
Process for the preparation of cysteamine bitartrate and product so obtained. The present inventi... |
|
|
Invention
|
Process for the preparation of cysteamine bitartrate and product so obtained.
The present invent... |
|
2020
|
Invention
|
Pharmaceutical formulation for carglumic acid. The present disclosure relates to a pharmaceutical... |
|
|
Invention
|
Treatment of hyperammonemia in patients with renal insufficiency. Disclosed herein are methods of... |
|
2019
|
Invention
|
3 receptor antagonists. This invention relates to compounds of formula I;
2/3 receptors.
|
|
|
Invention
|
P2x3 receptor antagonists. 32/332/32/3 receptors. |
|
|
Invention
|
Salt of cysteamine for the preparation of highly respirable particles. An inhalable microparticle... |
|
|
Invention
|
New salt of cysteamine for the preparation of highly respirable particles. The present invention ... |
|
|
Invention
|
Substituted [1,2,4]triazolo[4,3-a]pyrazines as modulators of mglu5 receptors. 5.
|
|
|
Invention
|
Triazole, imidazole and pyrrole condensed piperazine derivatives and their use as modulators of m... |
|
2018
|
Invention
|
Heterocyclylmethylidene derivatives and their use as modulators of mglur5 receptors. This inventi... |
|
2017
|
Invention
|
Pharmaceutical parenteral formulation containing carglumic acid. a from 5.5 to 9.0 at 25° C., pre... |
|
|
Invention
|
Pharmaceutical parenteral formulation containing carglumic acid. The present invention relates to... |
|
|
Invention
|
Formulations of cysteamine and cysteamine derivatives. Oral cysteamine formulation consisting of ... |
|
|
Invention
|
Prolonged release pharmaceutical composition comprising cysteamine or salt thereof. A prolonged r... |
|
2013
|
Invention
|
Multilayered pharmaceutical formulation. An oral trilayered formulation with multi-kinetic releas... |
|
|
Invention
|
Gastro-resistant delayed release pharmaceutical form. A solid gastro-resistant delayed release ph... |
|
2010
|
P/S
|
Chemical products for industrial, scientific and
photographic use, as well as for use in fertili... |
|
|
P/S
|
Pharmaceutical preparations, dietetic substances adapted for
medical use. Food supplements not a... |
|
|
P/S
|
Pharmaceutical preparations; dietetic substances adapted for medical use; dietetic foods or food ... |
|
2009
|
Invention
|
Process for the resolution of isoquinoline derivatives. A process for the resolution of racemic t... |
|
2007
|
Invention
|
Process for manufacturing microcrystalline lansoprazole form i. A process for manufacturing cryst... |
|
2006
|
Invention
|
Aldosterone receptor antagonists. Compounds of the formula (I), (R1 is one of a wide range of sub... |
|
|
Invention
|
Lercanidipine free base. The invention provides substantially pure lercanidipine free base, havin... |
|
|
Invention
|
Amorphous lercanidipine hydrochloride. The invention provides a substantially pure amorphous lerc... |
|
2005
|
Invention
|
Lercanidipine capsules. A modified release pharmaceutical composition comprises lercanidipine dis... |
|
|
Invention
|
Lercanidipine salts. The invention relates to new addition salts comprising lercanidipine and an ... |
|
|
Invention
|
Transmucosal delivery formulations. Transmucosal delivery formulations comprising a therapeutical... |
|
|
Invention
|
Combination therapy with 5-ht1a and 5-ht1b receptor antagonists. A compound having 5-HT1A antagon... |
|
2004
|
Invention
|
Sertraline hydrochloride form ii and methods for the preparation thereof. This invention relates ... |
|
|
Invention
|
Methods for preparing sertraline hydrochloride polymorphs. This invention relates to crystalline ... |
|
|
Invention
|
Combination therapy for hypertension using lercanidipine and an angiotensin ii receptor blocker. ... |
|
|
Invention
|
Selective mglu5 antagonists for treatment of neuromuscular dysfunction of the lower urinary tract... |
|
2003
|
Invention
|
1-phenylalkyl-piperazines. Compounds of formula (I) (R and R1 are a wide range of substituents, Q... |
|
|
Invention
|
Phenylalkylamines and pyridylalkylamines with serotoninergic receptor affinity. Compounds of form... |
|
|
Invention
|
N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic... |
|
2002
|
Invention
|
Heterocyclic compounds for use in the treatment of disorders of the urinary tract. Compounds of f... |
|
|
Invention
|
Use of selective cox-2 inhibitors for the treatment of urinary incontinence. Compounds that signi... |
|
|
Invention
|
Selective alpha 1 antagonists a + d. Described are derivatives with an adrenergic antagonistic ac... |
|
2000
|
Invention
|
Benzopyran derivatives. Benzopyran derivatives (I) (R = phenyl, alkoxycarbonyl, alkylcarbonyl, CO... |
|
|
Invention
|
Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists. Isoxazolecarboxamide ... |
|
|
Invention
|
Thienopyranecarboxamide derivatives. Compounds (I) (R = aryl, cycloalkyl or polyhaloalkyl, R1 = a... |
|
|
Invention
|
Cyclic amides and imides having selective antagonist activity at alpha-1d adrenergic receptor. Co... |
|
|
Invention
|
Use of selective antagonists of the α1b-adrenergic receptor for improvement of sexual dysfunction... |
|
|
P/S
|
Produits pharmaceutiques, vétérinaires et hygiéniques;
substances diététiques à usage medical. |
|
1998
|
P/S
|
Chemicals used in industry, science, agriculture, horticulture and forestry, but not in photograp... |
|
|
Invention
|
1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring. 1-(N-... |
|
|
Invention
|
1,4-disubstituted piperazines. Compounds of formula (I) (n = 1 or 2, Het = monocyclic heteroaryl,... |
|
|
Invention
|
Piperazine derivatives active on the lower urinary tract. Piperazine derivatives of formula (I) (... |
|
1994
|
P/S
|
Bleaching preparations and other substances for laundry use;
cleaning, polishing, grease removin... |
|
1985
|
P/S
|
Pharmaceutical, veterinary and sanitary preparations;
dietetic substances adapted for medical us... |
|
1983
|
P/S
|
Chemical products for use in industry, science, agriculture,
horticulture, sylviculture; artific... |
|
1982
|
P/S
|
Organic Chemicals and Fine Chemicals-Namely, Intermediates for Antibiotics, Synthetic Estrogens, ... |
|
1974
|
P/S
|
Chemicals of analytical or fine grade for pharmaceutical use. |
|
1972
|
P/S
|
Chemicals, namely amphetamine sulfate, benactyzine hydrochloride, stilbestrol, dimenhydrinate, di... |
|
|
P/S
|
Chemicals used in industry, science, photography,
agriculture, horticulture and forestry, soil f... |
|
1971
|
P/S
|
Préparations pharmaceutiques anti-inflammatoires et
sédatives. |
|
|
P/S
|
Produits pharmaceutiques, vétérinaires et hygiéniques;
substances diététiques à usage médical, a... |
|
|
P/S
|
Produits pharmaceutiques, vétérinaires et hygiéniques;
produits diététiques pour enfants et mala... |
|
1959
|
P/S
|
Pharmaceutical[, Veterinary, Hygienical and Medicated Dietetical Products, and Dietetical] Produc... |
|
1957
|
P/S
|
Pharmaceutical, veterinary and hygienic products, dietetic
goods for children and the sick, plas... |
